Boehringer will acquire Amgen's development and manufacturing facility in Fremont, Calif., for an undisclosed sum

Amgen Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Boehringer Ingelheim GmbH

Germany / Private Biopharma

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced